Cancer Research Aziza Shad  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kong, Y.
Right arrow Articles by Alman, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kong, Y.
Right arrow Articles by Alman, B. A.
[Cancer Research 64, 5795-5803, August 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Matrix Metalloproteinase Activity Modulates Tumor Size, Cell Motility, and Cell Invasiveness in Murine Aggressive Fibromatosis

Yuan Kong1,2, Raymond Poon1, Puviindran Nadesan1, Tamara Di Muccio1, Riccardo Fodde4, Rama Khokha5 and Benjamin A. Alman1,2,3

1 Program in Developmental Biology, The Hospital for Sick Children, Toronto, Ontario, Canada; 2 Departments of Laboratory Medicine and Pathobiology and 3 Surgery, University of Toronto, Toronto, Ontario, Canada; 4 MGC–Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; 5 Department of Medical Biophysics, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) regulate the degradation of extracellular matrix components and play important roles in the progression of select neoplastic processes. The locally invasive soft tissue tumor, aggressive fibromatosis (also called desmoid tumor), is caused by mutations resulting in ß-catenin-mediated T-cell factor (tcf)-dependent transcriptional activity. Because ß-catenin can regulate MMP expression, we investigated the expression of several MMPs and TIMPs in aggressive fibromatosis tumors that develop in Apc+/Apc1638N mice. Mmp-3 and Timp-1 were differentially regulated (5-fold and 0.5-fold, respectively) in tumors compared with normal fibrous tissue. Conditioned media from tumor cells showed an increased ability to degrade collagen, and inhibition of MMPs using GM6001 decreased the ability of the tumor cells to invade through Matrigel. Both the treatment of Apc/Apc1638N mice with GM6001 or crossing with a transgenic mouse that overexpresses Timp-1 resulted in a significant reduction in tumor volume. Surprisingly, overexpression of Timp-1 also resulted in a 50% increase in tumor number. Although TIMP-1 can induce growth stimulatory effects in some cell types, we found no difference in proliferation or apoptosis rate in cells from tumors that developed in the Timp-1–transgenic mice compared with mice that did not express the Timp-1 transgene, suggesting that TIMP-1 promotes aggressive fibromatosis tumor formation through an alternate mechanism. These data suggest that MMPs play a crucial role in regulating the invasiveness of mesenchymal cells and in modulating aggressive fibromatosis tumor progression. Because this is a locally invasive tumor, MMP inhibition could slow tumor growth and may prove to be an effective adjuvant therapy.




This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
H. S. Hosalkar, J. T. Torbert, E. J. Fox, T. F. Delaney, A. J. Aboulafia, and R. D. Lackman
Musculoskeletal Desmoid Tumors
J. Am. Acad. Ortho. Surg., April 1, 2008; 16(4): 188 - 198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kopitz, M. Gerg, O. R. Bandapalli, D. Ister, C. J. Pennington, S. Hauser, C. Flechsig, H.-W. Krell, D. Antolovic, K. Brew, et al.
Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling
Cancer Res., September 15, 2007; 67(18): 8615 - 8623.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. S. Tjandra, C. Hsu, I. Goh, A. Gurung, R. Poon, P. Nadesan, and B. A. Alman
IFN-{beta} Signaling Positively Regulates Tumorigenesis in Aggressive Fibromatosis, Potentially by Modulating Mesenchymal Progenitors
Cancer Res., August 1, 2007; 67(15): 7124 - 7131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Baliko, T. Bright, R. Poon, B. Cohen, S. E. Egan, and B. A. Alman
Inhibition of Notch Signaling Induces Neural Differentiation in Ewing Sarcoma
Am. J. Pathol., May 1, 2007; 170(5): 1686 - 1694.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. S. Cheon, Q. Wei, A. Gurung, A. Youn, T. Bright, R. Poon, H. Whetstone, A. Guha, and B. A. Alman
Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing
FASEB J, April 1, 2006; 20(6): 692 - 701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.